US approves first new Alzheimer’s drug in 20 years – BBC News
| June 10, 2021 | Cancer News
The very first brand-new therapy for Alzheimer’s disease for nearly 20 years has been accepted by regulators in the USA, leading the method for its use in the UK.
Aducanumab targets the underlying cause of Alzheimer’s, the most common form of dementia, instead of its symptoms.
Charities have actually invited the news of a brand-new treatment for the problem.
Scientists are split over its prospective influence because of unpredictability over the test results.
Please subscribe HERE http://bit.ly/1rbfUog
#BBCNews
